
The filing is a centerpiece of an agreement to settle thousands of cases against the company for its role in the opioids crises. But it is expected to be vigorously contested by a group of 26 states. BY JAN HOFFMAN AND MARY WILLIAMS WALSH https://ift.tt/2NgKCAo https://ift.tt/2AkObNF New York Times Health your-feed-science, Suits and Litigation (Civil), Bankruptcies, States (US), OxyContin (Drug), Opioids and Opiates, Drug Abuse and Traffic September 16, 2019 at 05:26AM
Comments
Post a Comment